A computational approach to aid clinicians in selecting anti-viral drugs
for COVID-19 trials
Abstract
We have created a database with all known viruses and their
corresponding antivirals. The database also accounts for the genomic
sequene of the viruses and the chemical structure of the drugs. This
database is used for drug repositioning, with the goal of finding drugs
suitable for treating COVID-19.